RA CAPITAL MANAGEMENT, L.P. - 20 Jan 2023 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role: 10%+ Owner
Signature: /s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Issuer symbol: FULC
Transactions as of: 20 Jan 2023
Net transactions value: +$24,999,988
Form type: 4
Filing time: 24 Jan 2023, 15:30:47 UTC
Previous filing: 10 Jan 2023
Next filing: 15 Apr 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FULC	Common Stock	Purchase	$24,999,988	+1,923,076	+20%	$13.00	11,609,704	20 Jan 2023	See Footnotes	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Held directly by RA Capital Healthcare Fund, L.P. (the "Fund").
F2	RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.

Content

Held directly by RA Capital Healthcare Fund, L.P. (the "Fund").

RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.